Nike could be re-rated lower as an apparel company with falling revenue and EPS that is struggling to show CEO Elliott Hill's turnaround is taking root after two years. Q1 revenue missed at $11.21B, FY27 revenue is guided down by a high-single-digit percentage versus a 2% expected decline, and adjusted EPS guidance of $1.15-$1.35 sits well below the $1.65 consensus, with weakness in China, sportswear and Jordan. Its 26.4x 2027 P/E is low only versus its ~30x history. x.com  x.com 

Nike is a damaged business, not just a damaged stock, so buying the dip is a mistake; a falling price only works when the business is still growing. Sportswear, just under half of revenue, is down low double digits, China is losing ground to local brands, and guided earnings don't cover the dividend this year. Insider buying hasn't helped: Tim Cook and directors bought around $59 in December 2025, Cook and the CEO near $42 in April, and shares now sit near $32. x.com  x.com 

Nike's brand concerns look priced in; stabilization, not sudden revenue acceleration, is what the speculative long needs. A few good campaigns and a return to large stores could help, though China consumers will be a drag. Short-term EPS is a poor indicator, and customers may return after trying other brands. x.com  x.com 

Nike is being re-rated from a growth powerhouse to a mature apparel utility now that its retro cycle of Jordan 1s, Dunks and Air Force 1s is exhausted. On, Hoka and New Balance have won runners and everyday buyers; in China it guides to a 20% revenue plunge as Anta and Li-Ning reach technical parity; and its DTC push cost it wholesale shelf space. Gross margin fell 130 bps to 40.2%, net income fell 35% and FY26 revenue is projected down 3-4%, so even about 15x forward earnings is expensive. … Show more

Nike's fundamentals have not yet followed, and insider buying by CEO Elliott Hill and board member Tim Cook did not fix the business. Q1 revenue fell about 4% to $11.2B, with China down 26%, Nike Sportswear down low double digits and Jordan down mid-teens. Management warned China could get worse and some turnaround pain could extend into fiscal 2028. Performance grew high single digits, running double digits and North America returned to growth, so Nike is not being written off. x.com 

Nike's push to reposition as a premium sports brand looks like the right route to recovery, including in Greater China. New CFO Dave Denton was clearer, and Alex Arnault's board seat, Jordan's return to scarcity, elite athlete deals and less discounting support it. EPS was fairly strong and margins are improving; guidance looks set deliberately low to beat, since management says the decline largely stems from its own choices. The dividend is safe; a full turnaround may take 3-5 years. x.com  … Show more

Nike looks overvalued at about 25.6x forward earnings for a business guiding to high-single-digit revenue declines. At $32 on $1.25 of EPS, per the lowered guidance @TrendSpider reports, plus a 5% dividend, tobacco stocks like Altria should triple if that is the going rate for shrinking sales. Nike does not merit a tobacco multiple: it angered its distributors, faces more premium rivals and new entrants, has less loyal customers, is no government-mandated duopoly and pays for costly marketing. … Show more

Nike's guidance for a high-single-digit revenue decline in fiscal 2027 is all investors need to know. x.com 

Nike's valuation pays investors to wait for a turnaround that will take longer than expected. It trades at just 16x earnings, near its lowest valuation ever, with a roughly 5% dividend yield, and would need a 127% rally to regain its 200-week moving average. Revenue is projected to fall another 4% in FY2027, but the business will grow again; the market prices it as if it were disappearing. Unlike Novo Nordisk, Nike faces no patent cliff. x.com  x.com 

Nike's situation is worse than expected. x.com